Anavex Life Sciences Corp (AVXL)

[sokol]

Everything I have seen remains positive for Anavex and its trials, including the news this morning. Although clinical trials designed or based on the precision the medicine approach may hold the hope to expedite the approval of drugs, these trials take time and need to show safety and efficacy for a number of patients over a reasonable period of time. On one hand Anavex has been criticized for reporting positive results for a small number of trial participants over a relatively short period of time, and it is also criticized for not reporting positive results for patients over a relatively short period of time. I think that even if Anavex reported positive results for some patients enrolled earlier than others, it would be criticized for jumping to conclusions about its drug before it has been tested on a greater numbers of patients for longer periods of time. Let's wait for the trials to be completed and for the results to be analyzed. In the meantime, I do not know of any sound basis to be negative about what Anavex has reported to date.